AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21314643 — intervention group
Group type: EXPERIMENTAL
Intervention: E (high-intensity physical resistance strength training and walking)
Number of subjects: 165
Study 21314643 — intervention group
Group type: EXPERIMENTAL
Intervention: SA (individualized social activity)
Number of subjects: 165
Study 21314643 — intervention group
Group type: EXPERIMENTAL
Intervention: ESA (E and SA combined)
Number of subjects: 165
Study 21314643 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 165
Study 19190632 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1000 mg m(‐2), d1, d8, 100‐min infusion) and Oxaliplatin (100 mg m(‐2), d1)
Number of subjects: 50
Study 19190632 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and Oxaliplatin combination
Number of subjects: 50
Study 16440332 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 U Botox in each parotid gland
Number of subjects: 32
Study 16440332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 12548062 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg)
Number of subjects: 33
Study 12548062 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (40 mg)
Number of subjects: 33
Study 11079654 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone (400 mg)
Number of subjects: 52
Study 11079654 — intervention group
Group type: COMPARATOR
Intervention: Control (no troglitazone)
Number of subjects: 52
Study 9366100 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg (PIR)
Number of subjects: 800
Study 9366100 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg (HCT)
Number of subjects: 800
Study 9366100 — intervention group
Group type: COMPARATOR
Intervention: Altizide 15 mg - Spironolactone 25 mg (ALT-SP)
Number of subjects: 800
Study 9366100 — intervention group
Group type: EXPERIMENTAL
Intervention: All drugs (PIR, HCT, ALT-SP)
Number of subjects: 800
Study 1608733 — intervention group
Group type: EXPERIMENTAL
Intervention: subliminal presentation of memory-improvement affirmations embedded in relaxing music
Number of subjects: 60
Study 1608733 — intervention group
Group type: EXPERIMENTAL
Intervention: supraliminal presentation of relaxing music
Number of subjects: 60
Study 1608733 — intervention group
Group type: COMPARATOR
Intervention: no sound
Number of subjects: 60
Study 3910541 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosoxacin 150 mg twice daily for 10 days
Number of subjects: 62
Study 3910541 — intervention group
Group type: COMPARATOR
Intervention: Triple tetracycline (Deteclo) 300 mg twice daily for 10 days
Number of subjects: 62
Study 31880078 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation (8 weeks, one home visit and seven once-weekly telephone calls)
Number of subjects: 58
Study 31880078 — intervention group
Group type: COMPARATOR
Intervention: Standard care (weekly social telephone calls)
Number of subjects: 58
Study 29521312 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface ECG-guided LV lead placement
Number of subjects: 80
Study 29521312 — intervention group
Group type: COMPARATOR
Intervention: Standard unguided CRT
Number of subjects: 80
Study 27716298 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 100
Study 27716298 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 100
Study 27716298 — intervention group
Group type: COMPARATOR
Intervention: CAMS and TAU
Number of subjects: 100
Study 27716298 — intervention group
Group type: EXPERIMENTAL
Intervention: CAMS
Number of subjects: 100
Study 24673575 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea extract (BTE)
Number of subjects: 12
Study 24673575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 22801416 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg rosuvastatin
Number of subjects: 116
Study 22801416 — intervention group
Group type: COMPARATOR
Intervention: 40 mg simvastatin/10 mg ezetimibe
Number of subjects: 116
Study 20026503 — intervention group
Group type: COMPARATOR
Intervention: Marlboro snus (MSNUS) with >50% reduction in cigarette consumption (DU group)
Number of subjects: 120
Study 20026503 — intervention group
Group type: COMPARATOR
Intervention: Marlboro snus (MSNUS) with complete cessation of cigarette smoking (SN group)
Number of subjects: 120
Study 20026503 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (CS) continuing to smoke their own brand
Number of subjects: 120
Study 20026503 — intervention group
Group type: COMPARATOR
Intervention: No tobacco products (NT group)
Number of subjects: 120
Study 19209795 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective endotracheal intubation (Group II)
Number of subjects: 90
Study 19209795 — intervention group
Group type: COMPARATOR
Intervention: Classical endotracheal intubation (Group I)
Number of subjects: 90
Study 15899726 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolife Ephedra Free (half the normal recommended dose)
Number of subjects: 20
Study 15899726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12789955 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral‐B Stages toothbrushes
Number of subjects: 0
Study 9583761 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg) plus benserazide (25 mg) taken three times per day for 28 days
Number of subjects: 25
Study 9583761 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 25
Study 9450173 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet (treatment A)
Number of subjects: 12
Study 9450173 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule (treatment B, Gramidil)
Number of subjects: 12
Study 9450173 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 12
Study 1929132 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound compression pads
Number of subjects: 120
Study 7145542 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of one or more abnormal features in parent or child
Number of subjects: 476
Study 7145542 — intervention group
Group type: EXPERIMENTAL
Intervention: Unkempt children
Number of subjects: 476
Study 7145542 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with abnormal bruises, burns, or bites
Number of subjects: 476
Study 7145542 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of unkempt condition and abnormal parenting pattern
Number of subjects: 476
Study 7145542 — intervention group
Group type: EXPERIMENTAL
Intervention: Unkempt child with abnormal parenting pattern
Number of subjects: 476
Study 31965170 — intervention group
Group type: EXPERIMENTAL
Intervention: Sectioning of the periareolar dermis in the experimental group
Number of subjects: 41
Study 31965170 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sectioning of the periareolar dermis)
Number of subjects: 41
Study 29791252 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait Modification Group (n = 8)
Number of subjects: 16
Study 29791252 — intervention group
Group type: COMPARATOR
Intervention: Control Group (n = 8)
Number of subjects: 16
Study 29339913 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week anti-inflammatory diet program
Number of subjects: 20
Study 29339913 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 24166562 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (A-tDCS) 1 mA for 10 min, n = 18
Number of subjects: 37
Study 24166562 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation 1 mA for 25 s, n = 19
Number of subjects: 37
Study 21771770 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 0.5‐1.0 g/kg
Number of subjects: 35
Study 21771770 — intervention group
Group type: COMPARATOR
Intervention: Control (saline equivalent volume)
Number of subjects: 35
Study 21771770 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 0.5 g/kg
Number of subjects: 35
Study 21771770 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 1.0 g/kg
Number of subjects: 35
Study 19416445 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of rubber dam
Number of subjects: 205
Study 19416445 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of matrix band and wedge
Number of subjects: 205
Study 19416445 — intervention group
Group type: COMPARATOR
Intervention: Baseline (before any dental treatment)
Number of subjects: 205
Study 17450065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair with a flat seat pan plus miscellaneous items
Number of subjects: 277
Study 17450065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair with a curved seat pan plus miscellaneous items
Number of subjects: 277
Study 17450065 — intervention group
Group type: COMPARATOR
Intervention: Miscellaneous items (control group)
Number of subjects: 277
Study 15476910 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg)
Number of subjects: 80
Study 15476910 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 mg)
Number of subjects: 80
Study 15476910 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 80
Study 15476910 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 80
Study 9413770 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic acidosis
Number of subjects: 0
Study 9413770 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction of metabolic acidosis
Number of subjects: 0
Study 9413770 — intervention group
Group type: COMPARATOR
Intervention: Healthy children (Control)
Number of subjects: 0
Study 8498314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 1.25 mg daily
Number of subjects: 210
Study 8498314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 2.5 mg daily
Number of subjects: 210
Study 8498314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5.0 mg daily
Number of subjects: 210
Study 8498314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10.0 mg daily
Number of subjects: 210
Study 8498314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 8498314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (all doses > 1.25 mg)
Number of subjects: 210
Study 8498314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 210
Study 3549810 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% topical minoxidil applied twice daily for 64 weeks
Number of subjects: 30
Study 3549810 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks, then 3% topical minoxidil for 52 weeks
Number of subjects: 30
Study 3549810 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of 3% topical minoxidil for a second year
Number of subjects: 30
Study 29849840 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training combined with increased physical activity (n=38)
Number of subjects: 76
Study 29849840 — intervention group
Group type: COMPARATOR
Intervention: Exercise training alone (n=38)
Number of subjects: 76
Study 26559015 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg.kg(‐1))
Number of subjects: 55
Study 26559015 — intervention group
Group type: COMPARATOR
Intervention: Control (6% hydroxyethyl starch)
Number of subjects: 55
Study 24566571 — intervention group
Group type: EXPERIMENTAL
Intervention: Capilen® cream
Number of subjects: 30
Study 24566571 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 30
Study 22726566 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied to one leg once a day for 14 days
Number of subjects: 11
Study 22726566 — intervention group
Group type: COMPARATOR
Intervention: Control (non-stimulated leg)
Number of subjects: 11
Study 20408017 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid carbon dioxide cooling shirt (CC)
Number of subjects: 10
Study 20408017 — intervention group
Group type: COMPARATOR
Intervention: No cooling (NC)
Number of subjects: 10
Study 18758393 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drugs (lamivudine, stavudine, zidovudine, nevirapine, nelfinavir, ritonavir, lopinavir) measured in breast milk using a novel extraction method and high-performance liquid chromatography-tandem mass spectrometry.
Number of subjects: 0
Study 16126716 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 10
Study 16126716 — intervention group
Group type: COMPARATOR
Intervention: Pacing
Number of subjects: 10
Study 12716814 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil
Number of subjects: 2283
Study 12716814 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2283
Study 10500060 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (800 mg/day)
Number of subjects: 10
Study 10500060 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (1500 mg/day)
Number of subjects: 10
Study 10500060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8924134 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 113
Study 8924134 — intervention group
Group type: COMPARATOR
Intervention: Non-steroid treatment (Control)
Number of subjects: 113
Study 1986897 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside administered using Abbott infusion pump
Number of subjects: 6
Study 1986897 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside administered using IMED infusion pump
Number of subjects: 6
Study 1986897 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside administered using 3M/AVI infusion pump
Number of subjects: 6
Study 1986897 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside administered using IVAC infusion pump
Number of subjects: 6
Study 1986897 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside administered using Kendall McGaw infusion pump
Number of subjects: 6
Study 6340183 — intervention group
Group type: EXPERIMENTAL
Intervention: Carprofen, 300 mg/day
Number of subjects: 28
Study 6340183 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin, 75 mg/day
Number of subjects: 28
Study 30803046 — intervention group
Group type: EXPERIMENTAL
Intervention: Antireflux metal stent (ARMS)
Number of subjects: 104
Study 30803046 — intervention group
Group type: COMPARATOR
Intervention: Covered self‐expandable metal stents (SEMS)
Number of subjects: 104
Study 29087809 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured postoperative physiotherapy
Number of subjects: 201
Study 29087809 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured postoperative physiotherapy (attended at least 50% of sessions)
Number of subjects: 201
Study 29087809 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative approach
Number of subjects: 201
Study 29087809 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (structured physiotherapy and standard approach)
Number of subjects: 201
Study 27484710 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipurpose solutions (MPS)
Number of subjects: 30
Study 27484710 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 30
Study 27484710 — intervention group
Group type: EXPERIMENTAL
Intervention: Different MPS
Number of subjects: 30
Study 25103686 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐Exercise (12-week intervention with maximum five face‐to‐face physical therapy contacts and a web‐based program)
Number of subjects: 200
Study 25103686 — intervention group
Group type: COMPARATOR
Intervention: Usual care (physical therapy)
Number of subjects: 200
Study 25103686 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐Exercise
Number of subjects: 200
Study 21926097 — intervention group
Group type: EXPERIMENTAL
Intervention: Room Air (RA) foam sclerotherapy
Number of subjects: 20
Study 21926097 — intervention group
Group type: COMPARATOR
Intervention: Carbon Dioxide (CO(2)) foam sclerotherapy
Number of subjects: 20
Study 20008708 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (1 mg)
Number of subjects: 693
Study 20008708 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (4 mg)
Number of subjects: 693
Study 20008708 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy (control group)
Number of subjects: 693
Study 17161478 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+AK-2123
Number of subjects: 333
Study 17161478 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 333
Study 15105032 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g beta‐hydroxy‐beta‐methylbutyrate, 5 g arginine, and 1.5 g lysine daily
Number of subjects: 50
Study 15105032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 12033481 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of practice nurses in the research project
Number of subjects: 100
Study 12033481 — intervention group
Group type: COMPARATOR
Intervention: Age, sex, membership of an independent practitioner association (IPA), number of half days worked, number of GPs working in a practice
Number of subjects: 100
Study 9876807 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal fluconazole 200 mg
Number of subjects: 5
Study 7866603 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg twice daily
Number of subjects: 37
Study 7866603 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide dinitrate (ISDN) 20 mg twice daily
Number of subjects: 37
Study 7866603 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of captopril and ISDN
Number of subjects: 37
Study 7866603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 2510288 — intervention group
Group type: EXPERIMENTAL
Intervention: rioprostil, 300 micrograms
Number of subjects: 12
Study 2510288 — intervention group
Group type: EXPERIMENTAL
Intervention: indomethacin, 75 mg and 50 mg
Number of subjects: 12
Study 2510288 — intervention group
Group type: COMPARATOR
Intervention: baseline, no treatment
Number of subjects: 12
Study 1130763 — intervention group
Group type: EXPERIMENTAL
Intervention: tobramycin
Number of subjects: 116
Study 1130763 — intervention group
Group type: COMPARATOR
Intervention: gentamicin
Number of subjects: 116
Study 31441500 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-layer closure technique
Number of subjects: 324
Study 31441500 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer closure technique
Number of subjects: 324
Study 31441500 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 324
Study 31381364 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) - loading dose followed by continuous infusion for 48 hours
Number of subjects: 60
Study 31381364 — intervention group
Group type: COMPARATOR
Intervention: Dextrose 5% (control group)
Number of subjects: 60
Study 31381364 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 60
Study 28548468 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct training method
Number of subjects: 89
Study 28548468 — intervention group
Group type: COMPARATOR
Intervention: Indirect training method
Number of subjects: 89
Study 26129900 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalitong granule (DG) 6 g 3 times daily
Number of subjects: 640
Study 26129900 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at points Zusanli (ST36), Zhongwan (CV12), Neiguan (PC6), Taichong (LR3), Gongsun (SP4) twice daily
Number of subjects: 640
Study 26129900 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of DG and EA
Number of subjects: 640
Study 26129900 — intervention group
Group type: COMPARATOR
Intervention: Control group: 5 mg mosapride 3 times, 20 mg pantoprazole, and 25 mg amitriptyline twice daily
Number of subjects: 640
Study 24057434 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one advice from a community pharmacist along with a weight loss handbook for self-study
Number of subjects: 66
Study 24057434 — intervention group
Group type: COMPARATOR
Intervention: Group counselling from the PCU staff as usual
Number of subjects: 66
Study 22097156 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (2 mg/kg per day or 3 mg/kg per day)
Number of subjects: 213
Study 22097156 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 213
Study 22097156 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 213
Study 17895911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible administration of micronutrient Sprinkles over 4 months
Number of subjects: 362
Study 17895911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible administration of micronutrient Sprinkles over 3 months
Number of subjects: 362
Study 17895911 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily administration of micronutrient Sprinkles over 2 months
Number of subjects: 362
Study 16432275 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam plasma concentrations
Number of subjects: 86
Study 16432275 — intervention group
Group type: COMPARATOR
Intervention: 1‐OH MDZ to midazolam plasma concentration ratios
Number of subjects: 86
Study 12975660 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC (docetaxel, doxorubicin, cyclophosphamide) chemotherapy (75/50/500 mg/m2 6x q3wk)
Number of subjects: 61
Study 12975660 — intervention group
Group type: COMPARATOR
Intervention: FAC (5‐fluorouracil, doxorubicin, cyclophosphamide) chemotherapy (500/50/500 mg/m2 6x q3wk)
Number of subjects: 61
Study 12975660 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC
Number of subjects: 61
Study 11079643 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg daily for four weeks)
Number of subjects: 9
Study 11079643 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside and monomethyl arginine
Number of subjects: 9
Study 8947886 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha 2b (r-IFN-alpha 2b) at doses of 5, 2.5, or 1.25 million units (MU) daily for a minimum of 14 days prior to transplantation and continuing for 42 days post-transplantation.
Number of subjects: 28
Study 8947886 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha 2b (r-IFN-alpha 2b) treatment.
Number of subjects: 28
Study 1329219 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus vincristine
Number of subjects: 0